Stock BIOSTAR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Biostar Pharmaceuticals, Inc. Nasdaq

Equities

US0906781036

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Biostar Pharmaceuticals, Inc.
2023 Biostar Pharmaceuticals, Inc. Announces FDA Approval of Utidelone Injectable Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer CI
2023 Biostar Pharma, Inc. Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BSPM Stock
  4. Stock
  5. News Biostar Pharmaceuticals, Inc.
  6. Analyst Reco.